
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
| Year | Volume | Number manuscripts | Number pages | Mean manuscript length |
|---|---|---|---|---|
| 2010 | 11 | 85 | 1036 | 12.2 |
| 2011 | 12 | 100 | 1156 | 11.6 |
| 2012 | 13 | 118 | 1397 | 11.8 |
| 2013 | 14 | 132 | 1612 | 12.2 |
| 2014 | 15 | 173 | 1952 | 11.3 |
| % growth (2010–2014) | 104% | 88% | ||
| Radiation Onc physics | Medical imaging | Radiation measurements | |||||
|---|---|---|---|---|---|---|---|
| Year | Volume | Number manuscripts | Number pages | Number manuscripts | Number pages | Number manuscripts | Number pages |
| 2010 | 11 | 57 | 728 | 11 | 143 | 8 | 93 |
| 2011 | 12 | 82 | 944 | 12 | 151 | 6 | 61 |
| 2012 | 13 | 94 | 1136 | 11 | 127 | 12 | 125 |
| 2013 | 14 | 114 | 1405 | 8 | 95 | 5 | 73 |
| 2014 | 15 | 132 | 1550 | 17 | 178 | 14 | 153 |
| % growth (2010–2014) | 132% | 113% | 55% | 24% | 75% | 65% | |
| 2010 | 2011 | 2012 | 2013 | 2014 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Topic | Number | % of issue | Number | % of issue | Number | % of issue | Number | % of issue | Number | % of issue |
|
| 7 | 11.5% | 7 | 9.2% | 7 | 7.9% | 6 | 5.5% | 8 | 6.5% |
|
| 12 | 19.7% | 15 | 19.7% | 20 | 22.5% | 33 | 30.0% | 27 | 22.0% |
|
| 8 | 13.1% | 6 | 7.9% | 11 | 12.4% | 9 | 8.2% | 15 | 12.2% |
|
| 7 | 11.5% | 4 | 5.3% | 7 | 7.9% | 1 | 0.9% | 2 | 1.6% |
|
| 9 | 14.8% | 12 | 15.8% | 16 | 18.0% | 18 | 16.4% | 20 | 16.3% |
|
| 10 | 16.4% | 9 | 11.8% | 6 | 6.7% | 9 | 8.2% | 15 | 12.2% |
|
| 3 | 4.9% | 3 | 3.9% | 5 | 5.6% | 1 | 0.9% | 3 | 2.4% |
|
| 4 | 6.6% | 14 | 18.4% | 11 | 12.4% | 14 | 12.7% | 23 | 18.7% |
|
| 1 | 1.6% | 6 | 7.9% | 6 | 6.7% | 19 | 17.3% | 10 | 8.1% |
| Volume 11 | Volume 15 | Volume 24 | ||||
|---|---|---|---|---|---|---|
| Country | # Manuscripts | % Manuscripts | # Manuscripts | % Manuscripts | # Manuscripts | % Manuscripts |
|
| 45 | 66% | 60 | 45% | 90 | 45% |
|
| 0 | 0% | 4 | 3% | 3 | 1% |
|
| 1 | 1% | 0 | 0% | 1 | 0% |
|
| 0 | 0% | 1 | 1% | 0 | 0% |
|
| 0 | 0% | 3 | 2% | 3 | 1% |
|
| 1 | 1% | 1 | 1% | 1 | 0% |
|
| 8 | 12% | 9 | 7% | 9 | 4% |
|
| 0 | 0% | 7 | 5% | 20 | 10% |
|
| 1 | 1% | 0 | 0% | 0 | 0% |
|
| 0 | 0% | 2 | 2% | 2 | 1% |
|
| 0 | 0% | 0 | 0% | 3 | 1% |
|
| 1 | 1% | 5 | 4% | 6 | 3% |
|
| 0 | 0% | 0 | 0% | 7 | 3% |
|
| 5 | 7% | 4 | 3% | 0 | 0% |
|
| 1 | 1% | 1 | 1% | 4 | 2% |
|
| 0 | 0% | 4 | 3% | 2 | 1% |
|
| 1 | 1% | 0 | 0% | 0 | 0% |
|
| 1 | 1% | 4 | 3% | 4 | 2% |
|
| 2 | 3% | 7 | 5% | 25 | 12% |
|
| 0 | 0% | 4 | 3% | 1 | 0% |
|
| 0 | 0% | 1 | 1% | 0 | 0% |
|
| 0 | 0% | 2 | 2% | 4 | 2% |
|
| 0 | 0% | 1 | 1% | 0 | 0% |
|
| 0 | 0% | 0 | 0% | 1 | 0% |
|
| 0 | 0% | 0 | 0% | 1 | 0% |
|
| 0 | 0% | 1 | 1% | 0 | 0% |
|
| 0 | 0% | 0 | 0% | 2 | 1% |
|
| 0 | 0% | 3 | 2% | 3 | 1% |
|
| 0 | 0% | 0 | 0% | 2 | 1% |
|
| 1 | 1% | 2 | 2% | 2 | 1% |
|
| 0 | 0% | 2 | 2% | 1 | 0% |
|
| 0 | 0% | 0 | 0% | 1 | 0% |
|
| 0 | 0% | 0 | 0% | 3 | 1% |
|
| 0 | 0% | 0 | 0% | 1 | 0% |
|
| 0 | 0% | 5 | 4% | 0 | 0% |
|
| 68 | 133 | 202 | |||
|
| 66% | 45% | 45% | |||
|
| 78% | 52% | 49% | |||
|
| 12 | 23 | 27 | |||
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Radiotherapy Techniques · Advances in Oncology and Radiotherapy · Radiation Therapy and Dosimetry
INTRODUCTION
1
The period 2010−2014, during which I served as Editor‐in‐Chief of the JACMP, was characterized by significant growth in the size of the journal. In this article, we examine the growth of the JACMP, both from the point of view of topic coverage and of the source of manuscripts.
MATERIALS AND METHODS
2
We examined entries in the URL https://aapm.onlinelibrary.wiley.com/loi/15269914. This URL is a browser that enables access to all back issues of the JACMP. To determine the magnitude of the increase in the size of the JACMP, we examined the following quantities:
- The number of manuscripts and number of pages in each volume.
- The categories that held the largest numbers of manuscripts, that is, Radiation Oncology Physics, Medical Imaging, and Radiation Measurements. Other topics, such as Radiation Protection and Regulations, Professional, and Education had too few manuscripts to establish meaningful statistics.
- We further subdivided Radiation Oncology Physics in more fine‐grained categories and examined trends in the following subcategories: brachytherapy treatment planning, external‐beam treatment planning, dosimetry, tumor localization, treatment delivery, stereotactic radiosurgery, proton treatment delivery, quality assurance, and tumor motion. In some cases, a manuscript could fit into more than one category. In that case an arbitrary decision by the author placed the manuscript in one or the other category.
- Finally, we compared the country of origin of manuscripts for the time period under study and the most recent issue of the JACMP. In situations in which authors came from different countries, the country of record was taken to be the country of the first author of the manuscript.
RESULTS
3
The results of each assessment are found in the following tables:
- The numbers of manuscripts, total number of pages, and mean length of a manuscript are illustrated in Table 1. We see in this table that during the period from 2010 to 2014 the number of manuscripts published more than doubled, with a corresponding increase in the number of pages. The mean manuscript length, however, remained approximately the same.
- Although the growth in the JACMP was significant, it was not uniform over subject areas. Table 2 indicates the number of manuscripts and number of pages for the topic Radiation Oncology physics, Medical Imaging, and Radiation Measurements. From this table we see that the greatest contribution to the increased number of manuscripts and number of pages is the increase in number of radiation oncology physics manuscripts. The increases in numbers of manuscripts on other topics was significant as well, but not as pronounced as the increase in number of manuscripts and number of pages devoted to radiation oncology physics (Tables 3 and 4).
- There does not appear to be any discernable trend in the distribution of topics.
- A significant change in the JACMP has been the growth in the number of countries from which manuscripts have been published. During the period 2010−2014 the number of manuscripts per year from the USA has increased from 45 to 60, but the percentage of manuscripts from the USA has decreased from 66% to 45%. Between 2014 and 2023 the number of manuscripts has further increased, but the percentage of manuscripts from the USA has remained the same. Moreover, the number of countries from which manuscripts have been published has increased from 12 in 2010 to 23 in 2014 to 27 in 2023.
CONCLUSION
4
The JACMP has seen significant growth in the period 2010−2014, growth that has continued to the present. One factor contributing to this growth is an increase in journal submissions in radiation oncology physics. This growth appears to be uniform across subtopics in radiation oncology physics. The second factor contributing to the growth of the journal is the number of foreign submissions. The fraction of manuscripts from the USA has decreased by a third in the 5‐year period from 2010 to 2014. It may be useful in planning for the future of the JACMP to examine the manuscript publication record for the most recent five‐year period (2019‐2023) to determine if the trends observed for 2010−2014 are continuing.
